Literature DB >> 12503673

Inflammatory myofibroblastic tumor.

Sangeeta Sawant1, L Kasturi, Alpa Amin.   

Abstract

Inflammatory myofibroblastic tumors are well described in lung and upper respiratory tract of young adults and children. Intra-abdominal forms of the disease are reported to occur most frequently in the liver, followed by stomach, bowel and spleen. A 13-year-old girl who had intermittent fever ranging from 99-101 degrees F of three months period and significant weight loss was referred as a case of pyrexia of unknown origin. The patient was subjected to laparotomy. A solid mass was found arising from the mesentery, four feet from the iliocaecal junction and was adherent to the wall of ileum. The patient became afebrile after the removal of the mass and has gained weight and remained well during the ten months since discharge.

Entities:  

Mesh:

Year:  2002        PMID: 12503673     DOI: 10.1007/bf02726027

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations.

Authors:  G Pettinato; J C Manivel; N De Rosa; L P Dehner
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

2.  Inflammatory pseudotumour of liver--a case report.

Authors:  A Gosavi; S Agashe; M Phansopkar; S S Jadhav; B R Agrawal
Journal:  Indian J Pathol Microbiol       Date:  1997-01       Impact factor: 0.740

Review 3.  Inflammatory myofibroblastic tumor in children.

Authors:  A K Souid; M C Ziemba; A S Dubansky; M Mazur; M Oliphant; F D Thomas; M Ratner; P D Sadowitz
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

4.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

Review 5.  Abdominal inflammatory myofibroblastic tumours in children.

Authors:  M D Stringer; P Ramani; C K Yeung; S N Capps; E M Kiely; L Spitz
Journal:  Br J Surg       Date:  1992-12       Impact factor: 6.939

Review 6.  Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor.

Authors:  S P Treissman; D A Gillis; C L Lee; M Giacomantonio; L Resch
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

7.  Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor.

Authors:  J M Meis; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

  7 in total
  6 in total

1.  [Inflammatory myofibroblastic tumor of the greater omentum in a 1.5-year-old boy].

Authors:  K Backhaus; S Grasshoff-Derr; K Ernestus; T Meyer
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

Review 2.  Mesenteric inflammatory pseudotumor: a case report and comprehensive literature review.

Authors:  Yusuf Yagmur; Sami Akbulut; Serdar Gumus
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  Inflammatory myofibroblastic tumor of the small bowel mesentery: an unusual cause of abdominal pain and uveitis.

Authors:  Audrey H Choi; Olga L Bohn; Timothy D Beddow; Christopher R McHenry
Journal:  J Gastrointest Surg       Date:  2011-01-05       Impact factor: 3.452

4.  A case of inflammatory myofibroblastic tumor originated from the greater omentum in young adult.

Authors:  Bong Hyeon Kye; Hyung Jin Kim; Se-Goo Kang; Changyoung Yoo; Hyeon-Min Cho
Journal:  J Korean Surg Soc       Date:  2012-05-29

5.  Inflammatory myofibroblastic tumor of the gallblader.

Authors:  Ismail Ozsan; Mustafa Ozsoy; Erkan Sahin; Ragıp Ortaç; Unal Aydın
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

6.  Abdominal inflammatory myofibroblastic tumor: report on four cases and review of literature.

Authors:  Alireza Mirshemirani; Ahmad Khaleghnejad Tabari; Naser Sadeghian; Siamak Shariat-Torbaghan; Marina Pourafkari; Leila Mohajerzadeh
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.